Wealth Advisory Solutions’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-779
Closed -$213K 148
2025
Q3
$213K Buy
+779
New +$213K 0.05% 133
2024
Q1
Sell
-18,312
Closed -$3.15M 133
2023
Q4
$3.15M Sell
18,312
-16,825
-48% -$2.59M 1.1% 29
2023
Q3
$5.64M Buy
35,137
+19,542
+125% +$3.53M 1.1% 26
2023
Q2
$3.41M Sell
15,595
-141
-0.9% -$31.4K 0.91% 35
2023
Q1
$3.45M Sell
15,736
-123
-0.8% -$26.7K 0.92% 35
2022
Q4
$3.3M Sell
15,859
-394
-2% -$86.6K 0.89% 33
2022
Q3
$3.55M Sell
16,253
-328
-2% -$74.7K 0.98% 30
2022
Q2
$3.48M Buy
+16,581
New +$3.53M 0.86% 46
2021
Q1
Sell
-2,033
Closed -$432K 184
2020
Q4
$432K Buy
+2,033
New +$405K 0.12% 101
2020
Q1
Sell
-18,940
Closed -$2.94M 189
2019
Q4
$2.94M Buy
+18,940
New +$2.73M 0.77% 37

Other funds holding RMD

Wealth Advisory Solutions's RMD Position: Q4 2025 in Review

Wealth Advisory Solutions sold out of ResMed (RMD) in Q4 2025, closing a stake of 779 shares — an estimated $213K sold.

Wealth Advisory Solutions first reported a position in RMD in Q4 2019 and held it in 10 quarters. The position peaked at $5.64M in Q3 2023. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Wealth Advisory Solutions reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Wealth Advisory Solutions sold 779 ResMed shares in Q4 2025, an estimated $213K.
  • Wealth Advisory Solutions first reported a position in ResMed in Q4 2019 and held it in 10 quarters.
  • Wealth Advisory Solutions's ResMed position peaked at $5.64M in Q3 2023.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Wealth Advisory Solutions's 13F filing for Q4 2025, filed 16 Jan 2026.